These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26471035)

  • 1. Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure.
    Pagliuca S; Legendre H; Morin S; Rabian F; Naveau L; Zine M; Wang L; Marchand T; Coman T; Xhaard A; Ferry C; Robin M; Peffault De Latour R; Socié G; Sicre de Fontbrune F
    Ann Hematol; 2016 Jan; 95(2):353-4. PubMed ID: 26471035
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
    Ringdén O
    Stem Cells Dev; 2009 Nov; 18(9):1243-6. PubMed ID: 19905962
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
    Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study.
    Aoki K; Ishikawa T; Ishiyama K; Aoki J; Itonaga H; Fukuda T; Kakihana K; Uchida N; Ueda Y; Eto T; Mori T; Kondo T; Iwato K; Morishima Y; Tanaka J; Atsuta Y; Miyazaki Y;
    Br J Haematol; 2015 Feb; 168(3):463-6. PubMed ID: 25228239
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure.
    Aboul Nour H; Patil N; Chewning JH; Di Stasi A; Salzman D; Innis-Shelton R; Lamb L; Mineishi S; Saad A
    Bone Marrow Transplant; 2017 Jan; 52(1):157-158. PubMed ID: 27526281
    [No Abstract]   [Full Text] [Related]  

  • 6. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.
    Mukherjee S
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplant for MDS: challenges and emerging strategies.
    Tamari R; Castro-Malaspina H
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):43-54. PubMed ID: 25659729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for myelodysplastic syndrome.
    Parmar S; de Lima M
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S37-44. PubMed ID: 19857589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplants in myelodysplastic syndromes.
    Wetzko K; Platzbecker U
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1011-22. PubMed ID: 25459176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity and nonmyeloablative conditioning regimens.
    Foss F; van Besien K
    Cancer Treat Res; 2009; 144():209-32. PubMed ID: 19779868
    [No Abstract]   [Full Text] [Related]  

  • 14. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.
    Epperla N; Pasquini M; Pierce K; Drobyski WR; Rizzo JD; Horowitz MM; Saber W; Zellner K; Ramirez S; Bartz K; Raj RV; Hari PN; Hamadani M
    Bone Marrow Transplant; 2017 Jan; 52(1):147-150. PubMed ID: 27479688
    [No Abstract]   [Full Text] [Related]  

  • 15. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
    Lang P; Teltschik HM; Feuchtinger T; Müller I; Pfeiffer M; Schumm M; Ebinger M; Schwarze CP; Gruhn B; Schrauder A; Albert MH; Greil J; Urban C; Handgretinger R
    Br J Haematol; 2014 Jun; 165(5):688-98. PubMed ID: 24588540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerism.
    Fuchida S; Nakano S; Yamada N; Uchida R; Okano A; Okamoto M; Maruya E; Saji H; Shimazaki C
    Bone Marrow Transplant; 2005 May; 35(10):1031-2. PubMed ID: 15806124
    [No Abstract]   [Full Text] [Related]  

  • 17. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study.
    Meuleman N; Tondreau T; Ahmad I; Kwan J; Crokaert F; Delforge A; Dorval C; Martiat P; Lewalle P; Lagneaux L; Bron D
    Stem Cells Dev; 2009 Nov; 18(9):1247-52. PubMed ID: 19309241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient.
    Shimada K; Narimatsu H; Morishita Y; Kohno A; Saito S; Kato Y
    Bone Marrow Transplant; 2006 Apr; 37(8):787-8. PubMed ID: 16501589
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful reduced-intensity HLA-haploidentical stem cell transplantation based on the concept of feto-maternal tolerance for an elderly patient with myelodysplastic syndrome.
    Obama K; Takemoto Y; Takatsuka Y; Utsunomiya A
    Bone Marrow Transplant; 2004 Jan; 33(2):253. PubMed ID: 14647244
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplant strategies for patients with myelodysplastic syndromes.
    Deeg HJ
    Curr Opin Hematol; 2006 Mar; 13(2):61-6. PubMed ID: 16456370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.